Advanced search
Publication Cover
Journal of Chemotherapy Volume 20, 2008 - Issue 1
Submit an article Journal homepage
19
Views
3
CrossRef citations to date
0
Altmetric
Antimicrobial Chemotherapy

Comparison of Rifampicin and Moxifloxacin Efficacy in an Experimental Model of Animal Brucellosis

N. Sezak
,
Z. Kuruuzum
,
N. Cakir
&
A. Yuce
Pages 58-62 | Published online: 18 Jul 2013

References

  • Hall WH. Modern chemotherapy for brucellosis in humans. Rev Infect Dis. 1990; 12: 1060–99.
  • Young EJ. BruceIla species. In: Mandell GL, Bennet JE, Dolin R, eds, Principles and Practice of Infectious Diseases, 4th edn. New York: Churchill Livingstone; 2000: 2386–93.
  • Arda B, Tuncel M, Yaimazhan T, Gokengin D, Gurel O. Efficacy of oral levofloxacin and dirithromycin alone and in combination with rifampicin in the treatment of experimental murine BruceIla abortus infection. Int J Antimicrob Agents. 2004; 23: 204–7.
  • Geyik MF, Dikici B, Kokoglu OF, Bosnak M, Celen MK, Hosoglu S, Ayaz C. Therapeutic effect of spiramycin in bru-cellosis. Pediatr Int. 2003; 45: 31–4.
  • Shasha B, Lang R, Rubinstein E. Therapy of experimen-tal murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin. Antimicrob Agents Chemother. 1992; 36: 973–6.
  • Shasha B, Lang R, Rubinstein E. Efficacy of combina-tions of doxycycline and rifampicin in the therapy of experi-mental mouse brucellosis. J Antimicrob Chemother. 1994 33: 545–51.
  • Lang R, Shasha B, Rubinstein E. Therapy of experimen- tal murine brucellosis with streptomycin alone and in combina-tion with ciprofloxacin, doxycycline, and rifampin. Antimicrob Agents Chemother. 1993 ; 37: 2333–6.
  • Yumuk Z, Dundar V. The effect of long-term ethanol feeding on efficacy of doxycycline plus rifampicin in the treat-ment of experimental brucellosis caused by BruceIla meliten-sis in rats. J Chemother. 2005; 17: 509–13.
  • Siefert HM, Domdey-Bette A, Henninger K, Hucke F, Kohlsdorfer C, Stass HH. Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species. J Antimicrob Chemother 1999; 43 (suppl):69-76.
  • Agalar C, Usubutun S, Turkyilmaz R. Ciprofloxacin and rifampicin versus doxycycline and rifampicin in the treatment of brucellosis. Eur J Clin Microbiol Infect Dis. 1999; 18: 535–8.
  • World Health Organization, Joint FAO/WHO Expert Committee on Brucellosis (Sixth report). 1986: Genova.
  • Ariza J, Gudiol F, Pallares R, Viladrich PF, Rufi G, Corredoira J, Miravitlles MR. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus strepto-mycin. A randomized, double-blind study. Ann Intern Med 1992; 117: 25–30.
  • Domagala JM. Structure-activity and structure-side-effect relationships for the quinolone antibacterials. J Antimicrob Chemother 1994; 33: 685–706.
  • Zhanel GG, Ennis K, Vercaigne L, Walkty A, Gin AS, Embil J, Smith H, Hoban DJ. A critical review of the fluoro-quinolones: focus on respiratory infections. Drugs. 2002; 62: 13–59.
  • Balfour JA, Lamb HM. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections. Drugs. 2000; 59: 115–39.
  • Leblebicio lu H, Akova M. Moxifloxacin. Flora, 2002; (suppl).
  • Ball P. Quinolone generations: natural history or natural selection? J Antimicrob Chemother. 2000; 46 (suppl): 17-24.
  • Trujillano-Martin I, Garcia-Sanchez E, Martinez IM, Fresnadillo MJ, Garcia-Sanchez JE, Garcia-Rodriguez JA. In vitro activities of six new fluoroquinolones against BruceIla melitensis. Antimicrob Agents Chemother. 1999; 43: 194–5.
  • Kocagoz S, Akova M, Altun B, Gur D, Hascelik G. In vitro activities of new quinolones against BruceIla melitensis isolated in a tertiary-care hospital in Turkey. Clin Microbiol Infect. 2002; 8: 240–2.
  • Rubinstein E, Lang R, Shasha B, Hagar B, Diamanstein L, Joseph G, et al. In vitro susceptibility of BruceIla meliten-sis to antibiotics. Antimicrob Agents Chemother. 1991; 35: 1925–7.
  • Akova M, Gur D, Livermore DM, Kocagoz T, Akalin HE. In vitro activities of antibiotics alone and in combination against BruceIla melitensis at neutral and acidic pHs. Antimicrob Agents Chemother. 1999; 43: 1298–300.
  • Sibai MB, Halim MA, el-Shaker MM, Khan BA, Qadri SM. Efficacy of ciprofloxacin for treatment of BruceIla melitensis infections. Antimicrob Agents Chemother. 1992; 36: 150-2.
  • Akova M, Uzun 0, Akalin HE, Hayran M, Unal S, Gur D. Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin. Antimicrob Agents Chemother. 1993; 37: 1831–4.
  • Falagas ME, Bliziotis IA. Quinolones for treatment of human brucellosis: critical review of the evidence from micro-biological and clinical studies. Antimicrob Agents Chemother. 2006; 50: 22–33.
  • Pappas G, Solera J, Akritidis N, Tsianos E. New approaches to the antibiotic treatment of brucellosis. Int J Antimicrob Agents. 2005; 26: 101–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.